Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Journal of Cancer Survivorship : Research and Practice|January 31, 2024
The development and flux of the University of Minnesota Survivorship Program: progress, challenges, and opportunitiesTara J Rick, Jill Lee, Sasha Skendzel, et al.American Heart Journal|March 31, 2015
Cardiovascular Safety Outcome Trials: A meeting report from the Cardiac Safety Research ConsortiumPhilip T Sager, Jonathan Seltzer, J Rick Turner, et al.Journal of Clinical Pharmacology|April 20, 2018
Drug-induced Proarrhythmia and Torsade de Pointes: A Primer for Students and Practitioners of Medicine and PharmacyJ Rick Turner, Ignacio Rodriguez, Emily Mantovani, et al.Journal of the American Society of Hypertension : JASH|May 17, 2015
Renal denervation therapy for hypertension: pathways for moving development forwardWilliam B White, Zorina S Galis, Jeffrey Henegar, et al.American Heart Journal|February 3, 2015
Centralized adjudication of cardiovascular end points in cardiovascular and noncardiovascular pharmacologic trials: a report from the Cardiac Safety Research ConsortiumJonathan H Seltzer, J Rick Turner, Mary Jane Geiger, et al.JCO Global Oncology|March 10, 2021
Impact of COVID-19 on Cancer Care Delivery in Africa: A Cross-Sectional Survey of Oncology Providers in AfricaYehoda M Martei, Tara J Rick, Temidayo Fadelu, et al.American Heart Journal|December 11, 2017
Enabling social listening for cardiac safety monitoring: Proceedings from a drug information association-cardiac safety research consortium cosponsored think tankHarry A Seifert, Raleigh E Malik, Mondira Bhattacharya, et al.Journal of the American Society of Hypertension : JASH|November 25, 2014
Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda, MD, U.S.A., October 10th 2013William B White, J Rick Turner, Domenic A Sica, et al.Therapeutic Innovation & Regulatory Science|September 18, 2018
Clinical Development Approaches and Statistical Methodologies to Prospectively Assess the Cardiovascular Risk of New Antidiabetic Therapies for Type 2 DiabetesMary Jane Geiger, Cyrus Mehta, J Rick Turner, et al.American Heart Journal|March 30, 2013
Assessment of drug-induced increases in blood pressure during drug development: report from the Cardiac Safety Research ConsortiumPhilip Sager, Jeffrey Heilbraun, J Rick Turner, et al.Pageof 8